Nagata K, Tezuka K, Kuramitsu M, Fuchi N, Hasegawa Y, Hamaguchi I
J Virol. 2024; 98(2):e0186223.
PMID: 38294250
PMC: 10878273.
DOI: 10.1128/jvi.01862-23.
Mizuguchi M, Takahashi Y, Tanaka R, Fukushima T, Tanaka Y
Pathogens. 2020; 9(2).
PMID: 32012672
PMC: 7168584.
DOI: 10.3390/pathogens9020082.
Kunihiro M, Fujii H, Miyagi T, Takahashi Y, Tanaka R, Fukushima T
Viruses. 2016; 8(7).
PMID: 27409630
PMC: 4974526.
DOI: 10.3390/v8070191.
Atluri V, Hidalgo M, Samikkannu T, Kurapati K, Nair M
Neural Plast. 2015; 2015:138979.
PMID: 26649202
PMC: 4663354.
DOI: 10.1155/2015/138979.
Shida H
Front Microbiol. 2012; 3:179.
PMID: 22783232
PMC: 3390767.
DOI: 10.3389/fmicb.2012.00179.
Entry of human T-cell leukemia virus type 1 is augmented by heparin sulfate proteoglycans bearing short heparin-like structures.
Tanaka A, Jinno-Oue A, Shimizu N, Hoque A, Mori T, Islam S
J Virol. 2012; 86(6):2959-69.
PMID: 22238310
PMC: 3302340.
DOI: 10.1128/JVI.05783-11.
Role of resident CNS cell populations in HTLV-1-associated neuroinflammatory disease.
Lepoutre V, Jain P, Quann K, Wigdahl B, Khan Z
Front Biosci (Landmark Ed). 2009; 14(3):1152-68.
PMID: 19273122
PMC: 2739244.
DOI: 10.2741/3300.
In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection.
Asquith B, Zhang Y, Mosley A, de Lara C, Wallace D, Worth A
Proc Natl Acad Sci U S A. 2007; 104(19):8035-40.
PMID: 17483473
PMC: 1861853.
DOI: 10.1073/pnas.0608832104.
T-cell control by human T-cell leukemia/lymphoma virus type 1.
Franchini G, Fukumoto R, Fullen J
Int J Hematol. 2003; 78(4):280-96.
PMID: 14686485
DOI: 10.1007/BF02983552.
Alpha interferon inhibits human T-cell leukemia virus type 1 assembly by preventing Gag interaction with rafts.
Feng X, Heyden N, Ratner L
J Virol. 2003; 77(24):13389-95.
PMID: 14645593
PMC: 296084.
DOI: 10.1128/jvi.77.24.13389-13395.2003.
Cell-free human T-cell leukemia virus type 1 binds to, and efficiently enters mouse cells.
Sun B, Nitta T, Shoda M, Tanaka M, Hanai S, Hoshino H
Jpn J Cancer Res. 2002; 93(7):760-6.
PMID: 12149141
PMC: 5927073.
DOI: 10.1111/j.1349-7006.2002.tb01317.x.
Bovine leukemia virus SU protein interacts with zinc, and mutations within two interacting regions differently affect viral fusion and infectivity in vivo.
Gatot J, Callebaut I, Van Lint C, Demonte D, Kerkhofs P, Portetelle D
J Virol. 2002; 76(16):7956-67.
PMID: 12134000
PMC: 155115.
DOI: 10.1128/jvi.76.16.7956-7967.2002.
Rat CRM1 is responsible for the poor activity of human T-cell leukemia virus type 1 Rex protein in rat cells.
Hakata Y, Yamada M, Shida H
J Virol. 2001; 75(23):11515-25.
PMID: 11689633
PMC: 114738.
DOI: 10.1128/JVI.75.23.11515-11525.2001.
Molecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus Type-1 (HTLV-1).
Johnson J, Harrod R, Franchini G
Int J Exp Pathol. 2001; 82(3):135-47.
PMID: 11488989
PMC: 2517711.
DOI: 10.1046/j.1365-2613.2001.00191.x.
Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12(I) protein.
Johnson J, Nicot C, Fullen J, Ciminale V, Casareto L, Mulloy J
J Virol. 2001; 75(13):6086-94.
PMID: 11390610
PMC: 114324.
DOI: 10.1128/JVI.75.13.6086-6094.2001.
RNA polymerase III transcription: its control by tumor suppressors and its deregulation by transforming agents.
Brown T, Scott P, Stein T, Winter A, White R
Gene Expr. 2000; 9(1-2):15-28.
PMID: 11097422
PMC: 5964957.
DOI: 10.3727/000000001783992713.
Inhibition of cell-free human T-cell leukemia virus type 1 infection at a postbinding step by the synthetic peptide derived from an ectodomain of the gp21 transmembrane glycoprotein.
Jinno A, Haraguchi Y, Shiraki H, Hoshino H
J Virol. 1999; 73(11):9683-9.
PMID: 10516085
PMC: 113011.
DOI: 10.1128/JVI.73.11.9683-9689.1999.
The distinction blurs between an autoimmune versus microbial hypothesis in multiple sclerosis.
Hafler D
J Clin Invest. 1999; 104(5):527-9.
PMID: 10487765
PMC: 483283.
DOI: 10.1172/JCI8193.
Human T-lymphocyte transformation with human T-cell lymphotropic virus type 2.
Tarsis S, Yu M, Parks E, Persaud D, Munoz J, Parks W
J Virol. 1998; 72(1):841-6.
PMID: 9420297
PMC: 109446.
DOI: 10.1128/JVI.72.1.841-846.1998.
71-kilodalton heat shock cognate protein acts as a cellular receptor for syncytium formation induced by human T-cell lymphotropic virus type 1.
Sagara Y, Ishida C, Inoue Y, Shiraki H, Maeda Y
J Virol. 1998; 72(1):535-41.
PMID: 9420256
PMC: 109405.
DOI: 10.1128/JVI.72.1.535-541.1998.